(Q33839174)

29 July 2017

1 reference

title

Multidisciplinary management of metastatic colorectal cancer (English)

1 reference

29 July 2017

1 reference

1 reference

Yoon SS

1

1 reference

29 July 2017

Tanabe KK

series ordinal

2

1 reference

29 July 2017

publication date

1 November 1998

1 reference

29 July 2017

1 reference

29 July 2017

volume

7

1 reference

29 July 2017

issue

3-4

1 reference

29 July 2017

page(s)

197-207

1 reference

29 July 2017

cites work

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Clinical perspective of human colorectal cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Follow-Up of Patients with Colorectal Cancer A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

A prospective randomized study of follow-up after radical surgery for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Editorial: Large-bowel cancer-The current status of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Meta-analysis of randomized trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Surgical treatment of liver metastases in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Hepatic resection for metastases from colorectal carcinoma is of dubious value

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Detection of focal hepatic masses: prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

CT during arterial portography: diagnostic pitfalls

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Improved staging of liver tumors using laparoscopic intraoperative ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Radioimmunoguided surgery for patients with liver metastases secondary to colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Liver imaging. A surgeon's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Is there a survival difference? Meta-analysis of the published literature

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Surgical Treatment of Hepatic Metastases From Colorectal Cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Surgical management of patients with primary operable colorectal cancer and synchronous liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Patient selection for hepatic resection of colorectal metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Liver resection for colorectal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

The influence of intraoperative hypotension and perioperative blood transfusion on disease-free survival in patients with complete resection of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Repeat liver resections from colorectal metastasis. Repeat Hepatic Metastases Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Repeat hepatectomy for colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Hepatic resection following systemic chemotherapy for metastatic colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Treatment of colorectal liver metastases by cryotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

New trends in the surgical treatment of colorectal cancer liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Saline-enhanced radio-frequency tissue ablation in the treatment of liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Pharmacologic rationale for regional drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

A prospective, randomized evaluation of the treatment of colorectal cancer metastatic to the liver

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Pulmonary metastases: MR imaging with surgical correlation--a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Surgical resection of pulmonary metastases from colorectal cancer. 10-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Surgical resection of pulmonary metastases from colorectal adenocarcinoma. Special reference to repeated pulmonary resections

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Colorectal lung metastases: results of surgical excision

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Lung resection for colorectal metastases. 10-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Pulmonary resection for metastases of colorectal origin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Surgery for lung metastases from colorectal cancer: analysis of prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Resection of hepatic and pulmonary metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Resection of hepatic and pulmonary metastases in patients with colorectal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Is resection of pulmonary and hepatic metastases warranted in patients with colorectal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Brain metastases from colorectal carcinoma. The long term survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Colorectal carcinoma and brain metastasis: distribution, treatment, and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

Resection of brain metastases from colorectal carcinoma in 73 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-7404%2899%2900022-5

7 January 2021

10.1016/S0960-7404(99)00022-5

Identifiers

DOI

1 reference

29 July 2017

1 reference